WOCKPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > wockpharma

Technical Analysis

Technical Strength: 7.9 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 56.7. According to RSI analysis, wockpharma just got above it's resistance level and showing good signal. 9.0 WOCKPHARMA RSI Chart
MACD (?) MACD: 6.25 and Signal Line: 0.747. According to MACD analysis, wockpharma is technically strong. 8.0 WOCKPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, wockpharma is in a uptrend. Support level is at 769. 9.0 WOCKPHARMA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, wockpharma is in a uptrend. Support level is at 775. 9.0 WOCKPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.858. According to bollinger bands, wockpharma is technically strong. 7.0 WOCKPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 785.5142 and 769.95. Resistance level is 835.9. 6.5 WOCKPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 30.2 NA WOCKPHARMA Average True Range Chart
Average Directional Index (?) ADX is 16.4 which means WOCKPHARMA is in a trading range and there is no trend. NA WOCKPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
April 26, 2018
Open Price 783.6
High Price 804.8
Low Price 766.6
Close Price 794.75
Absolute Change 15.05
Percentage Change 1.93%
Weekly Change 4.17%
Monthly Change 8.39%
Yearly Change 7.37%
52-week high 1012.0
52-week low 530.65
Corporate Actions
ExDate Purpose
July 24, 2017 ANNUAL GENERAL MEETING
November 17, 2016 INT DIV RS 10/- PER SHARE
November 17, 2016 INTERIM DIVIDEND
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)1
Confidence in Beta4.54%
Market Capital Rs. 8781.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 18.68
TTM Price-to-Earnings (P/E) Ratio 42.5
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 26 April 2018: Deliverable Quantity:1.96e+05 NA WOCKPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 26 April 2018: Daily Volatility:0.4184 NA WOCKPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 26 April 2018: PCR_OI:0.339 PCR:0.378 NA WOCKPHARMA PCR Chart
Option Pain (?) 26 April 2018: Max Pain:780.0 NA WOCKPHARMA Option Pain Chart
Premium (?) 26 April 2018 Premium: -3.9 Futures OI:401400.0 NA WOCKPHARMA Premium Chart
Option_MAX_OI (?) 26 April 2018: Price:794.75 Put with maximum OI:800.0 Call with maximum OI:840.0 NA WOCKPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
April 26, 2018 790.85 401400.0 2078.0 2837.0 794.75
May 31, 2018 800.95 3281400.0 1847.0 2552.0 794.75
June 28, 2018 784.15 6300.0 3.0 3.0 794.75

Announcements

April 12, 2018 Shareholders meeting Wockhardt Limited has informed the Exchange with copy of minutes of Postal Ballot
April 11, 2018 Disc. under Reg.30 of SEBI (SAST) Reg.2011 Promoter of the Company has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 15, 2018 January 29, 2018 Results Inter-alia, to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended December 31, 2017.
October 10, 2017 October 30, 2017 Results inter-alia, to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2017.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 734.4 Rs. 750.5 Rs. 772.6 Rs. 788.7 Rs. 810.8 Rs. 826.9 Rs. 849